Overview

Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects

Status:
Completed
Trial end date:
2017-08-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics, safety, and tolerability of the autoinjector and pre-filled syringe of SB4 in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Samsung Bioepis Co., Ltd.
Treatments:
Etanercept